Directive 2011/24/EU on patients' rights in cross-border healthcare

Directive 2011/24/EU on patients' rights in cross-border healthcare
Title	Directive 2011/24/EU on patients' rights in cross-border healthcare
Type	European Union directive
Adopted	9 March 2011
Legal basis	Treaty on the Functioning of the European Union
Status	In force

Directive 2011/24/EU on patients' rights in cross-border healthcare establishes rules on access to healthcare across the European Union for insured persons and specified beneficiaries, setting standards for cooperation, information and reimbursement while balancing national health systems and the Charter of Fundamental Rights of the European Union. The directive translates jurisprudence from the Court of Justice of the European Union into a framework that interfaces with national law, cross-border networks and patient safety initiatives led by entities such as the European Commission and the European Centre for Disease Prevention and Control.

Background and Legal Framework

Adopted against a backdrop of seminal rulings by the Court of Justice of the European Union including the C-158/96 Kohll and C-120/95 Decker cases, the directive reflects developments under the Treaty on the Functioning of the European Union and principles established in the Charter of Fundamental Rights of the European Union. Its legal architecture engages institutions such as the European Parliament, the Council of the European Union and the European Commission, and interacts with instruments like the Regulation (EC) No 883/2004 and the Patients' Rights Directive debates preceding 2011. The directive further aligns with cooperative mechanisms linked to the European Medicines Agency and the European Centre for Disease Prevention and Control on quality and safety.

Key Provisions

The directive sets out entitlement to reimbursement for healthcare obtained in another Member State of the European Union and mechanisms for cross-border cooperation on health technology assessment via the European Network for Health Technology Assessment. It obliges Member State of the European Union governments to designate national contact points and to exchange information through the Public Health Programme structures. Provisions address recognition of prescriptions across borders, coordination with the Social Security Coordination frameworks such as Regulation (EC) No 883/2004 and requirements for ensuring continuity of care compatible with decisions from the Court of Justice of the European Union.

Implementation and National Contact Points

Implementation requires each Member State of the European Union to establish national contact points with duties defined by the European Commission. These contact points serve as interfaces with stakeholders including national health ministries like the Ministry of Health (France), statutory bodies like the National Health Service (England), and agencies such as the National Institute for Health and Care Excellence or the Robert Koch Institute. The directive envisages cooperation platforms akin to networks formed by the European Reference Networks and aligns reporting obligations with systems used by the European Centre for Disease Prevention and Control and the European Medicine Agency for pharmacovigilance.

Reimbursement and Prior Authorization

Reimbursement provisions require that insured persons from one Member State of the European Union may seek reimbursement for planned or unplanned care in another Member State of the European Union subject to specified limits, following principles developed in cases such as C-372/04 Watts. The directive delineates circumstances for prior authorization where healthcare costs might pose risks to the sustainability of national schemes, invoking coordination with national payers like France's Assurance Maladie or Germany's Federal Joint Committee (G-BA). It also specifies interactions with EU-wide instruments such as the European Health Insurance Card and social security coordination protocols under Regulation (EC) No 883/2004.

Patient Rights and Safety Measures

Patients are entitled to transparent information on rights, quality and safety, provided through national contact points and public registers comparable to those maintained by the European Medicines Agency and the European Centre for Disease Prevention and Control. The directive mandates safeguards for informed consent, continuity of care and access to medical records, intersecting with standards promoted by the World Health Organization Regional Office for Europe and patient organizations like the European Patients' Forum. Quality assurance measures encourage adherence to clinical guidance from bodies such as the European Network for Health Technology Assessment and the European Centre for Disease Prevention and Control.

Impact, Compliance and Case Law

The directive has influenced litigation and administrative practice interpreted by the Court of Justice of the European Union in follow-up judgments and has prompted national reforms across countries including France, Germany, United Kingdom, Poland and Spain. Compliance monitoring involves the European Commission and dialogues with agencies such as the European Observatory on Health Systems and Policies and the Organisation for Economic Co-operation and Development. The directive catalysed the development of European Reference Networks and has featured in cases concerning reimbursement, prior authorization and cross-border recognition of prescriptions with jurisprudential antecedents in Kohll and Decker decisions.

Category:European Union directives Category:Health law Category:Patient rights